C-Cure (human adult BM-derived somatic cell therapy)
/ Celyad Oncology
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
April 04, 2011
C-Cure Multicenter Trial: Lineage Specified Bone Marrow Derived Cardiopoietic Mesenchymal Stem Cells for Treatment of Ischemic Cardiomyopathy
(ACC 2011)
- N=45; The C-Cure study demonstrates the feasibility and safety profile of administering lineage-specified mesenchymal stem cells for cardiac repair in ischemic cardiomyopathy; Efficacy signals related to improvements in left ventricular and clinical performance are consistent with a generalized therapeutic benefit
Cardiovascular
1 to 1
Of
1
Go to page
1